“20 Years of CAPT: How Far We Have Come”
October 17-18, 2016
MaRS Discovery District
The abstracts presented at the CAPT 2016 Conference are available online
J Popul Ther Clin Pharmacol Vol 23(3):e204-e230; November 8, 2016
© 2016 Canadian Society of Pharmacology and Therapeutics. All rights reserved
Session 1 – Navigating Health System Silos – Promoting Innovative Policies and Best Practices
Session 2 – Models and Methods in Health Economics and the Decision-Making Process
Session 4 – Innovation, Uncertainty and Reimbursement Processes in Precision Medicine in Oncology
Session 5 – The Future of Health Data Accessibility in Canada
Session 6 – What Happens to Patient Access and the Role of HTA in an Increasingly Affordability- Focused Market?
Session 7 – Access to Innovative Medicines and Value: The Fine Balance
Session 8 – National Pharmacare- Part Deux
Student Podium Award was presented to Richard Morrow, oral presentation # 2
Are the benefits of statin cholesterol reduction over-estimated by the Cholesterol Treatment Trialists A meta-regression study of bias in statin trials
Student Poster Award was presented to Justin Lee, poster # 46
Characterizing the senior high cost healthcare user in Ontario: a preliminary analysis
Kris Schindel Award was presented to Dr. Roy West
2016 Conference Partners
CAPT would like to thank the partners that provided funding to make the 2016 annual conference possible
- Amgen Canada Inc.
- Merck Canada Inc.
- Janssen Pharmaceutical Companies of Johnson and Johnson
- Pfizer Canada Inc.
- AstraZeneca Canada Inc.
- Bayer Canada Inc.
- Boehringer-Ingelheim Canada
- Pivina Consulting Inc.
- Takeda Canada Inc.
- Telus Health Analytics
- Hoffmann-La Roche Ltd.
- HOPE Research Centre
- In Initiative Inc.
- Institute of Health Economics
- J.L. Glennie Consulting Inc.
- Mapol Inc.
- Patient Access Solutions
- PharmaKARe Consulting
- Purdue Pharma
- Shire Pharma Canada
- UCB Canada